http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2762511-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92535b89ab45cee9622828040c6d5178
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-729
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-729
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
filingDate 2021-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98e37a7d2568875c734f07f9516f12dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cbbbd2bd13e66e20f8e812c2bf7ede1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecadda1e04c1e70d69c4de128a7d1834
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6a98717f0f3b91774273ada4a87a023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a1be81c8a5fb7e0d4bf08205c4a10ba
publicationDate 2021-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2762511-C1
titleOfInvention Composition of bioresorbable 3d matrix for restoring bone tissue defects
abstract FIELD: medicine. n SUBSTANCE: invention relates to the field of medicine. A composition of a bioresorbable 3D matrix for the restoration of bone tissue defects is proposed. The composition includes the following components, parts by weight: casein 5% aqueous solution - 20; hyaluronic acid 2.5% aqueous solution - 40; chondroitin sulfate 0.2% aqueous solution - 10; licorice 3% water infusion - 20; polyethylene glycol 1500 - 3; agar-agar - 6. n EFFECT: improving the structure and characteristics of the 3D matrix, increasing the safety of its use, increasing the ability to implant into tissue, as well as simplifying and accelerating the process of its manufacture. n 1 cl, 3 ex, 2 tbl, 9 dwg
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2786443-C1
priorityDate 2021-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2476236-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2509554-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2508131-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2218895-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2624854-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14982
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53477707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415712569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414801397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945

Total number of triples: 47.